Medicare Enrolled
Dr. Todd Shenkenberg, M.D.
Hematology & Oncology · Harlingen, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shenkenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shenkenberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shenkenberg
Dr. Todd Shenkenberg is a hematology & oncology specialist in Harlingen, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shenkenberg performed 140,220 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shenkenberg received a total of $23,687 from 106 pharmaceutical and/or device companies across 1624 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shenkenberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in TX
$23,687 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗140,220
Medicare services
Top 3% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
44,800 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
30,300 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 15,400 | $43 | $70 |
| Denosumab injection (Prolia/Xgeva) | 13,500 | $18 | $43 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
6,854 | $0 | $0 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,819 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,818 | $8 | $22 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
3,752 | $10 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,547 | $63 | $122 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,280 | $6 | $22 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,007 | $10 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
914 | $61 | $115 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
876 | $0 | $4 |
| Anti-nausea injection (Aloxi/palonosetron) | 830 | $1 | $31 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
780 | $11 | $45 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
499 | $47 | $120 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
497 | $21 | $60 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
449 | $27 | $89 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
438 | $94 | $267 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 416 | $20 | $46 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
332 | $1 | $6 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
330 | $13 | $30 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
316 | $4 | $15 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
300 | $0 | $2 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
285 | $15 | $75 |
| Anti-nausea injection (ondansetron/Zofran) | 276 | $0 | $0 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
272 | $3 | $7 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
235 | $1 | $2 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
211 | $16 | $38 |
| PSA test (prostate cancer screening) | 195 | $18 | $41 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
146 | $91 | $145 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
143 | $20 | $60 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
130 | $7 | $15 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
121 | $129 | $235 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $134 | $568 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
109 | $19 | $42 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
96 | $49 | $125 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
94 | $4 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
90 | $49 | $130 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
87 | $16 | $20 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
86 | $7 | $16 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
86 | $24 | $51 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
72 | $7 | $184 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
48 | $50 | $100 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
48 | $31 | $75 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
41 | $4 | $11 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $23 | $95 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
31 | $2 | $6 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
30 | $24 | $25 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
25 | $33 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $85 | $182 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
18 | $62 | $135 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
15 | $40 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $98 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
85.5% medium
13.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,687
Total received (2018-2024)
Avg $3,384/year across 7 years
Top 19% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
106
Companies
1,624
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,082
2023
$4,095
2022
$3,782
2021
$3,503
2020
$2,791
2019
$3,270
2018
$3,164
Payments by company (2024)
PFIZER INC.
$352
AstraZeneca Pharmaceuticals LP
$327
E.R. Squibb & Sons, L.L.C.
$219
Astellas Pharma US Inc
$190
Bayer Healthcare Pharmaceuticals Inc.
$166
Novartis Pharmaceuticals Corporation
$160
Merck Sharp & Dohme LLC
$151
Daiichi Sankyo Inc.
$148
Genentech USA, Inc.
$141
Regeneron Healthcare Solutions, Inc.
$140
Janssen Biotech, Inc.
$84
Eisai Inc.
$83
Incyte Corporation
$78
Celgene Corporation
$76
PUMA BIOTECHNOLOGY, INC.
$71
Pharmacosmos Therapeutics Inc.
$65
Genmab U.S., Inc.
$62
GENZYME CORPORATION
$58
SOBI, INC
$54
ARRAY BIOPHARMA INC
$49
TAIHO ONCOLOGY, INC.
$41
BeiGene USA, Inc.
$39
GlaxoSmithKline, LLC.
$30
Tolmar, Inc.
$27
Fennec Pharmaceuticals, Inc.
$26
Mirati Therapeutics, Inc.
$25
PharmaEssentia USA Corporation
$23
SpringWorks Therapeutics, Inc.
$23
ABBVIE INC.
$20
Octapharma USA, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$19
Gilead Sciences, Inc.
$17
ADC Therapeutics America, Inc.
$16
Sumitomo Pharma America, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Sirtex Medical Inc
$14
Tempus AI, Inc
$14
TerSera Therapeutics LLC
$13
Ipsen Biopharmaceuticals, Inc
$13
Top 3 companies account for 29.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,876
Novartis Pharmaceuticals Corporation
$1,740
PFIZER INC.
$1,703
Janssen Biotech, Inc.
$1,333
AstraZeneca Pharmaceuticals LP
$1,185
Amgen Inc.
$1,157
Merck Sharp & Dohme Corporation
$959
Genentech USA, Inc.
$882
Astellas Pharma US Inc
$874
GENZYME CORPORATION
$801
Seagen Inc.
$778
Merck Sharp & Dohme LLC
$670
Incyte Corporation
$570
Eisai Inc.
$555
Celgene Corporation
$545
Daiichi Sankyo Inc.
$438
EISAI INC.
$358
Bayer Healthcare Pharmaceuticals Inc.
$327
PUMA BIOTECHNOLOGY, INC.
$265
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
Gilead Sciences, Inc.
$253
Regeneron Healthcare Solutions, Inc.
$246
Teva Pharmaceuticals USA, Inc.
$244
BeiGene USA, Inc.
$222
GlaxoSmithKline, LLC.
$220
Pharmacyclics LLC, An AbbVie Company
$190
Verastem, Inc.
$186
Takeda Pharmaceuticals U.S.A., Inc.
$180
SOBI, INC
$172
Puma Biotechnology, Inc.
$170
EMD Serono, Inc.
$160
Lilly USA, LLC
$159
Exelixis Inc.
$153
Bayer HealthCare Pharmaceuticals Inc.
$151
Kite Pharma, Inc.
$148
TerSera Therapeutics LLC
$146
Rigel Pharmaceuticals, Inc.
$135
Octapharma USA, Inc.
$128
Dova Pharmaceuticals
$126
Karyopharm Therapeutics Inc.
$118
ABBVIE INC.
$109
Genmab U.S., Inc.
$108
ARRAY BIOPHARMA INC
$107
AbbVie, Inc.
$105
JAZZ PHARMACEUTICALS INC.
$96
Sobi, Inc
$90
Taiho Oncology, Inc.
$90
TAIHO ONCOLOGY, INC.
$89
Pharmacosmos Therapeutics Inc.
$88
Sirtex Medical Inc
$88
AVEO Pharmaceuticals, Inc.
$84
Deciphera Pharmaceuticals Inc.
$82
Ipsen Biopharmaceuticals, Inc
$74
Janssen Pharmaceuticals, Inc
$67
Myovant Sciences Inc.
$67
AbbVie Inc.
$67
SANOFI-AVENTIS U.S. LLC
$65
Coherus Biosciences Inc.
$62
TESARO, Inc.
$60
Helsinn Therapeutics (U.S.), Inc.
$59
Jazz Pharmaceuticals Inc.
$57
Amneal Pharmaceuticals LLC
$51
Blueprint Medicines Corporation
$50
Clovis Oncology, Inc.
$50
Heron Therapeutics, Inc.
$49
ADC Therapeutics America, Inc.
$46
Kyowa Kirin, Inc.
$43
Spectrum Pharmaceuticals Inc.
$43
Sandoz Inc.
$42
Secura Bio, Inc.
$42
AMAG Pharmaceuticals, Inc.
$42
PharmaEssentia USA Corporation
$41
Immunocore Limited
$41
Agios Pharmaceuticals, Inc.
$41
Sumitomo Pharma America, Inc.
$36
Myriad Genetic Laboratories, Inc.
$32
Pharming Healthcare, Inc.
$32
MorphoSys, US Inc.
$30
CTI BioPharma Corp.
$29
Tolmar, Inc.
$27
Fennec Pharmaceuticals, Inc.
$26
Alexion Pharmaceuticals, Inc.
$26
Mirati Therapeutics, Inc.
$25
SpringWorks Therapeutics, Inc.
$23
Adaptive Biotechnologies Corporation
$22
Epizyme, Inc.,
$20
Otsuka America Pharmaceutical, Inc.
$19
Foundation Medicine, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$18
Grifols USA, LLC
$18
Tactile Systems Technology Inc
$17
Janssen Scientific Affairs, LLC
$17
Array BioPharma Inc.
$16
Sebela Pharmaceuticals Inc.
$16
Pharmacyclics LLC, an AbbVie Company
$15
ViiV Healthcare Company
$15
Tempus AI, Inc
$14
Immunomedics, Inc.
$13
Melinta Therapeutics, LLC
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Acrotech Biopharma LLC
$12
Aveo Pharmaceuticals, Inc.
$12
Seattle Genetics, Inc.
$11
Servier Pharmaceuticals LLC
$11
R-Pharm US LLC
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$7
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AVASTIN · AYVAKIT · Abraxane · Alecensa · Alphanate · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABENUVA · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · Columvi · Copiktra · Creon · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE CDX · Fabhalta · Farydak · Flexitouch Plus · Folotyn · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · Gazyva · HEMLIBRA · HERZUMA · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · INQOVI · Imbruvica · Ixempra · JADENU · JAKAFI · JEVTANA · Jivi · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LOKELMA · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MOTOFEN · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orbactiv · PADCEV · PANZYGA · PIQRAY · POLIVY · POTELIGEO · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · REXULTI · ROLVEDON · RUCONEST · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SOMAVERT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truxima · Turalio · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
4
County median income
$51,334
Nearest hospital to ZIP centroid (approximate)
VHS HARLINGEN HOSPITAL COMPANY LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shenkenberg is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shenkenberg experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Shenkenberg performed 44,800 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shenkenberg receive payments from pharmaceutical companies?
Yes. Dr. Shenkenberg received a total of $23,687 from 106 companies across 1,624 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shenkenberg's costs compare to other hematology & oncology specialists in Harlingen?
Dr. Shenkenberg's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shenkenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Harlingen
Browse hematology & oncology specialists in Harlingen ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology